Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEMBOREXANT vs LETROZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEMBOREXANT vs LETROZOLE: Safety Overview

Metric LEMBOREXANT LETROZOLE
Total FAERS Reports 989 31,154
Deaths Reported 44 3,024
Death Rate 4.4% 9.7%
Hospitalizations 278 8,637
Average Patient Age 58.9 yrs 61.8 yrs
% Female Patients 63.4% 98.9%
FDA Approval Date Apr 7, 2020 Apr 19, 2012
Manufacturer Eisai Inc. NuCare Pharmaceuticals,Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription